A new SARS-CoV-2 spike protein biosensor chip was successfully deployed for simultaneous measurements of IgG, IgA, and IgM using only 2 µl of serum per patient
The materials are expressly designed to support overall system QC and CLIA compliance and are intended for the calibration, or calibration verification, of both cholesterol and uric acid “wet” assays on clinical testing system
High-throughput system enables laboratories to double or even triple their testing capacity to support global efforts to return communities back to work and school